COMMERCIALIZATION OF STEM CELL THERAPY FOR THE TREATMENT OF DIABETIC RETINOPATHY

Bibliographic Details
Main Author: Shanmugam, Shiva Prasad
Language:English
Published: Case Western Reserve University School of Graduate Studies / OhioLINK 2010
Subjects:
Online Access:http://rave.ohiolink.edu/etdc/view?acc_num=case1278691262
id ndltd-OhioLink-oai-etd.ohiolink.edu-case1278691262
record_format oai_dc
spelling ndltd-OhioLink-oai-etd.ohiolink.edu-case12786912622021-08-03T05:33:51Z COMMERCIALIZATION OF STEM CELL THERAPY FOR THE TREATMENT OF DIABETIC RETINOPATHY Shanmugam, Shiva Prasad Biology Diabetic Retinopathy is one of the leading causes of blindness or vision loss in working-age adults. Millions of adults over age forty are affected by the diseases and there exists an impending need for a safe and effective treatment. The purpose of this study is to demonstrate the scientific and market potential of a novel stem cell therapy being developed as an alternative treatment. The aim is to treat diabetic retinopathy through the process of therapeutic angiogenesis with ex vivo expanded stem cells transfected with VEGF-PDGF growth factors. This promotes the formation of fully functional blood vessels in the retina of the eye, and restores vision. 2010-07-28 English text Case Western Reserve University School of Graduate Studies / OhioLINK http://rave.ohiolink.edu/etdc/view?acc_num=case1278691262 http://rave.ohiolink.edu/etdc/view?acc_num=case1278691262 unrestricted This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws.
collection NDLTD
language English
sources NDLTD
topic Biology
spellingShingle Biology
Shanmugam, Shiva Prasad
COMMERCIALIZATION OF STEM CELL THERAPY FOR THE TREATMENT OF DIABETIC RETINOPATHY
author Shanmugam, Shiva Prasad
author_facet Shanmugam, Shiva Prasad
author_sort Shanmugam, Shiva Prasad
title COMMERCIALIZATION OF STEM CELL THERAPY FOR THE TREATMENT OF DIABETIC RETINOPATHY
title_short COMMERCIALIZATION OF STEM CELL THERAPY FOR THE TREATMENT OF DIABETIC RETINOPATHY
title_full COMMERCIALIZATION OF STEM CELL THERAPY FOR THE TREATMENT OF DIABETIC RETINOPATHY
title_fullStr COMMERCIALIZATION OF STEM CELL THERAPY FOR THE TREATMENT OF DIABETIC RETINOPATHY
title_full_unstemmed COMMERCIALIZATION OF STEM CELL THERAPY FOR THE TREATMENT OF DIABETIC RETINOPATHY
title_sort commercialization of stem cell therapy for the treatment of diabetic retinopathy
publisher Case Western Reserve University School of Graduate Studies / OhioLINK
publishDate 2010
url http://rave.ohiolink.edu/etdc/view?acc_num=case1278691262
work_keys_str_mv AT shanmugamshivaprasad commercializationofstemcelltherapyforthetreatmentofdiabeticretinopathy
_version_ 1719421766420398080